{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "Y",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QCX",
      "openfda": {
        "k_number": [
          "DEN170055"
        ],
        "registration_number": [
          "1000393132",
          "1820334"
        ],
        "fei_number": [
          "1000393132",
          "1820334"
        ]
      },
      "review_panel": "AN",
      "medical_specialty": "AN",
      "device_name": "Retrograde Intubation Set",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Anesthesiology",
      "device_class": "2",
      "definition": "A retrograde intubation device is a prescription device used to perform retrograde intubation via the cricothyroid membrane. The device may contain or be labeled for use with guidewires and intubating catheters, in addition to needles (21 CFR 8685090), syringe (21 CFR 880.5860), and hemostats (21 CFR 878.4800).",
      "regulation_number": "868.5095",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}